↓ Skip to main content

Dove Medical Press

Clinical efficacy of Spasmofen® suppository in the emergency treatment of renal colic: a randomized, double-blind, double-dummy comparative trial

Overview of attention for article published in Drug Design, Development and Therapy, May 2014
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (74th percentile)
  • High Attention Score compared to outputs of the same age and source (84th percentile)

Mentioned by

policy
1 policy source
twitter
2 X users
googleplus
1 Google+ user

Citations

dimensions_citation
7 Dimensions

Readers on

mendeley
44 Mendeley
Title
Clinical efficacy of Spasmofen® suppository in the emergency treatment of renal colic: a randomized, double-blind, double-dummy comparative trial
Published in
Drug Design, Development and Therapy, May 2014
DOI 10.2147/dddt.s62571
Pubmed ID
Authors

Mostafa Yakoot, Amel Salem, Sameh Yousef, Sherine Helmy

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 44 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 44 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 10 23%
Student > Postgraduate 6 14%
Student > Bachelor 3 7%
Student > Doctoral Student 2 5%
Student > Ph. D. Student 2 5%
Other 4 9%
Unknown 17 39%
Readers by discipline Count As %
Medicine and Dentistry 14 32%
Nursing and Health Professions 3 7%
Veterinary Science and Veterinary Medicine 1 2%
Biochemistry, Genetics and Molecular Biology 1 2%
Environmental Science 1 2%
Other 5 11%
Unknown 19 43%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 5. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 27 December 2018.
All research outputs
#6,754,036
of 25,374,647 outputs
Outputs from Drug Design, Development and Therapy
#427
of 2,268 outputs
Outputs of similar age
#59,964
of 242,177 outputs
Outputs of similar age from Drug Design, Development and Therapy
#6
of 39 outputs
Altmetric has tracked 25,374,647 research outputs across all sources so far. This one has received more attention than most of these and is in the 73rd percentile.
So far Altmetric has tracked 2,268 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.1. This one has done well, scoring higher than 80% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 242,177 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 74% of its contemporaries.
We're also able to compare this research output to 39 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 84% of its contemporaries.